| Tuning β-sheet peptide self-assembly and hydrogelation behavior by modification of sequence hydrophobicity and aromaticity CJ Bowerman, W Liyanage, AJ Federation, BL Nilsson Biomacromolecules 12 (7), 2735-2745, 2011 | 211 | 2011 |
| Substituent effects on the self-assembly/coassembly and hydrogelation of phenylalanine derivatives W Liyanage, BL Nilsson Langmuir 32 (3), 787-799, 2016 | 99 | 2016 |
| Multicomponent dipeptide hydrogels as extracellular matrix-mimetic scaffolds for cell culture applications W Liyanage, K Vats, A Rajbhandary, DSW Benoit, BL Nilsson Chemical Communications 51 (56), 11260-11263, 2015 | 80 | 2015 |
| Spontaneous transition of self-assembled hydrogel fibrils into crystalline microtubes enables a rational strategy to stabilize the hydrogel state W Liyanage, WW Brennessel, BL Nilsson Langmuir 31 (36), 9933-9942, 2015 | 58 | 2015 |
| Microwave-assisted cyclization of unprotected dipeptides in water to 2, 5-piperazinediones and self-assembly study of products and reagents M Kurbasic, S Semeraro, AM Garcia, S Kralj, E Parisi, C Deganutti, ... Synthesis 51 (14), 2829-2838, 2019 | 30 | 2019 |
| Strategy to identify improved n-terminal modifications for supramolecular phenylalanine-derived hydrogelators BL Abraham, W Liyanage, BL Nilsson Langmuir 35 (46), 14939-14948, 2019 | 29 | 2019 |
| Cross-linking approaches to tuning the mechanical properties of peptide π-electron hydrogels W Liyanage, HAM Ardoña, HQ Mao, JD Tovar Bioconjugate Chemistry 28 (3), 751-759, 2017 | 23 | 2017 |
| Dendrimer–siRNA Conjugates for Targeted Intracellular Delivery in Glioblastoma Animal Models W Liyanage, T Wu, S Kannan, RM Kannan ACS Applied Materials & Interfaces 14 (41), 46290-46303, 2022 | 21 | 2022 |
| Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery HT Hsueh, RT Chou, U Rai, W Liyanage, YC Kim, MB Appell, J Pejavar, ... Nature communications 14 (1), 2509, 2023 | 19 | 2023 |
| Impact of gelation method on thixotropic properties of phenylalanine-derived supramolecular hydrogels E Quigley, J Johnson, W Liyanage, BL Nilsson Soft Matter 16 (44), 10158-10168, 2020 | 18 | 2020 |
| Fluorescence detection of cationic amyloid fibrils in human semen D Easterhoff, JTM DiMaio, W Liyanage, CW Lo, W Bae, TM Doran, ... Bioorganic & medicinal chemistry letters 23 (18), 5199-5202, 2013 | 16 | 2013 |
| Synthesis of carbapyochelins via diastereoselective azidation of 5-(ethoxycarbonyl) methylproline derivatives W Liyanage, L Weerasinghe, RK Strong, JR Del Valle The Journal of organic chemistry 73 (18), 7420-7423, 2008 | 16 | 2008 |
| Redox-sensitive reversible self-assembly of amino acid–naphthalene diimide conjugates W Liyanage, PW Rubeo, BL Nilsson Interface Focus 7 (6), 20160099, 2017 | 12 | 2017 |
| Synthesis and conformational analysis of bicyclic extended dipeptide surrogates S Ranatunga, W Liyanage, JR Del Valle The Journal of organic chemistry 75 (15), 5113-5125, 2010 | 11 | 2010 |
| Amyloid‐Inspired Optical Waveguides from Multicomponent Crystalline Microtubes W Liyanage, NMB Cogan, BL Nilsson ChemNanoMat 2 (8), 800-804, 2016 | 7 | 2016 |
| miRNA-211 maintains metabolic homeostasis in medulloblastoma through its target gene long-chain acyl-CoA synthetase 4 M Yuan, I Mahmud, K Katsushima, K Joshi, O Saulnier, R Pokhrel, B Lee, ... Acta Neuropathologica Communications 11 (1), 203, 2023 | 1 | 2023 |
| Microglial-Targeted nSMase2 Inhibitor Fails to Reduce Tau Propagation in PS19 Mice M Huang, C Tallon, X Zhu, KDJ Huizar, S Picciolini, AG Thomas, L Tenora, ... Pharmaceutics 15 (9), 2364, 2023 | 1 | 2023 |
| Supplementary materials for machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery RT Chou, HT Hsueh, U Rai, W Liyanage, YC Kim, MB Appell, J Pejavar, ... | 1 | 2023 |
| Microglial-targeted nSMase2 inhibitor fails to reduce tau spread in the animal model of Alzheimer's disease M Huang, C Tallon, X Zhu, K Huizar, S Piccirillo, AG Thomas, L Tenora, ... Alzheimer's Association International Conference, 2024 | | 2024 |
| Journey from lab to clinic: Design, preclinical, and clinical development of systemic, targeted dendrimer-N-acetylcysteine (D-NAC) nanomedicines. W Liyanage, N Kale, S Kannan, RM Kannan Advances in Pharmacology (San Diego, Calif.) 100, 119-155, 2024 | | 2024 |
